Current Drug Safety

Editor-in-Chief:

Dr. Seetal Dodd
University of Melbourne
Geelong, Melbourne
Australia

Back

Drug Withdrawals in the United States: A Systematic Review of the Evidence and Analysis of Trends

Volume:2   Issue:3
Pp: 177-185
Amalia M. Issa, Kathryn A. Phillips, Stephanie Van Bebber, Hima G. Nidamarthy, Karen E. Lasser, Jennifer S. Haas, Brian K. Alldredge, Robert M. Wachter and David W. Bates
DOI: 10.2174/157488607781668855

QT Prolongation and Safety in the Indian Population

Volume:2   Issue:3
Pp: 200-203
Jayesh Dabhi and Anita Mehta
DOI: 10.2174/157488607781668873

Oleamide Derivatives are Prototypical Anti-Metastasis Drugs that Act by Inhibiting Connexin 26

Volume:2   Issue:3
Pp: 204-211
Hiroshi Nojima, Yusuke Ohba and Yasuyuki Kita
DOI: 10.2174/157488607781668837

Safety of Drug Eluting Stents: Current Concerns and Controversies

Volume:2   Issue:3
Pp: 212-219
Shahzad G. Raja and Geoffrey A. Berg
DOI: 10.2174/157488607781668918

Zolpidem and Traffic Safety - The Importance of Treatment Compliance

Volume:2   Issue:3
Pp: 220-226
Joris C. Verster, Edmund R. Volkerts, Berend Olivier, William Johnson and Laura Liddicoat
DOI: 10.2174/157488607781668882

Desmopressin 30 Years in Clinical Use: A Safety Review

Volume:2   Issue:3
Pp: 232-238
Johan Vande Walle, Mette Stockner, Ann Raes and Jens P. Norgaard
DOI: 10.2174/157488607781668891